Managing Gout Flare-Up in Patients Taking Mounjaro (Tirzepatide)

Acute Flare Treatment Options

The American College of Rheumatology strongly recommends three first-line options for treating the acute gout flare, with selection based on patient comorbidities and contraindications 2
Prednisone 30-35 mg daily for 3-5 days is highly effective and generally safer than NSAIDs, particularly in patients with cardiovascular disease or diabetes, according to the American College of Rheumatology 2, 3
Colchicine 1.2 mg followed by 0.6 mg one hour later (total 1.8 mg on day 1) is recommended if treatment can be initiated within 12 hours of symptom onset, as suggested by the American College of Rheumatology 2, 3
Low-dose colchicine is strongly recommended over high-dose regimens due to similar efficacy with fewer adverse effects, according to the American College of Rheumatology 2
Full FDA-approved doses of NSAIDs (e.g., naproxen 500 mg twice daily, indomethacin 50 mg three times daily) are effective when started early, but should be used with caution in patients with renal impairment, peptic ulcer disease, or uncontrolled hypertension 2, 4
Intra-articular corticosteroid injection is highly effective for monoarticular or oligoarticular flares involving accessible joints, as recommended by the American College of Rheumatology 2, 3

There is no evidence that tirzepatide worsens gout flares or interacts with gout medications, according to the American College of Rheumatology 1, 2
Weight loss from tirzepatide may actually improve long-term gout management by reducing hyperuricemia, as suggested by the American College of Rheumatology 2
Early treatment initiation is crucial for optimal effectiveness, and patients should be advised to self-medicate at first warning symptoms, according to the American College of Rheumatology 3

The American College of Rheumatology conditionally recommends starting urate-lowering therapy (ULT) during the gout flare rather than waiting for resolution, provided appropriate anti-inflammatory prophylaxis is given 1, 5, 6
Continue the current urate-lowering therapy without interruption during the flare, as stopping ULT can cause serum urate fluctuations that may trigger additional flares, according to the American College of Rheumatology 5
Start allopurinol at low dose (100 mg daily) with concomitant anti-inflammatory prophylaxis (colchicine 0.5-1 mg/day or low-dose prednisone <10 mg/day) for 3-6 months, as recommended by the American College of Rheumatology 5, 3

Do not stop Mounjaro, as there is no interaction with gout treatments and weight loss benefits long-term gout control, according to the American College of Rheumatology 2
Do not delay treatment, as waiting reduces effectiveness significantly, according to the American College of Rheumatology 3
Do not use high-dose colchicine regimens, as they cause marked side effects without additional benefit, according to the American College of Rheumatology 4
Do not stop existing ULT during a flare, as this causes urate fluctuations and may prolong symptoms, according to the American College of Rheumatology 5

Apply topical ice to the affected joint for additional symptomatic relief, as recommended by the American College of Rheumatology 2, 3
Continue treatment until the gout attack has completely resolved, according to the American College of Rheumatology 3